JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 11 2037-2043
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurata, C.
Right arrow Articles by Tawarahara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurata, C.
Right arrow Articles by Tawarahara, K.

Enhanced Cardiac Clearance of Iodine-123-MIBG in Chronic Renal Failure

Chinori Kurata, Yasushi Wakabayashi, Sakae Shouda, Kenichi Okayama, Tatsuo Yamamoto, Akira Ishikawa, Kazuo Suzuki, Tamie Ishizuka, Shinji Sakamoto and Kei Tawarahara

Third and First Departments of Internal Medicine and Departments of Urology, Radiology, Clinical Laboratories, Hamamatsu University School of Medicine, Hamamatsu, Japan
Department of Internal Medicine, Hamamatsu Red Cross Hospital, Hamamatsu, Japan

Correspondence: For correspondence or reprints contact: Chinori Kurata, MD, Third Department of Internal Medicine, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-31, Japan.

ABSTRACT

We studied myocardial accumulation and clearance of [123I]metaiodobenzylguanidine (MIBG) along with measurements of plasma norepinephrine concentrations. Methods: Myocardial imaging with MIBG and plasmanorepinephrine concentration measurements were performed in 21 patients with chronic renal failure on dialysis and 11 control subjects. Dynamic acquisitions, begun immediately after MIBG injection, and planar images 15 and 150 min after injection were used to measure early and late myocardial uptake and clearance rates of MIBG from the heart. Results: Early and late MIBG uptake was not significantly different from that in controls but MIBG clearance was significantly more rapid in controls. Based on echocardiographic findings, the patients were divided into three subgroups: those without left ventricular hypertrophy and dysfunction (n = 10), with hypertrophy (n = 4) and with dysfunction (n = 7). Among controls and the three patient subgroups, MIBG clearance was significantly higherin all the subgroups and also was significantly higher in patients with dysfunction than in those without hypertrophy and dysfunction. Plasma norepinephrine levels were significantly higher in patients than in controls and correlated significantly with the clearance rate. Conclusion: MIBG clearance from the heart was rapid in patients with chronic renal failure on dialysis, particularly those with left ventricular dysfunction or hypertrophy, suggesting cardiac sympathetic overactivity in these patients.

Key Words: iodine-123-MIBG • chronic renal failure • norepinephrine • left ventricular hypertrophy • congestive heart failure




This article has been cited by other articles:


Home page
JNMHome page
C. Kurata, A. Uehara, and A. Ishikawa
Improvement of Cardiac Sympathetic Innervation by Renal Transplantation
J. Nucl. Med., July 1, 2004; 45(7): 1114 - 1120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.